Temporal leukocyte numbers and granulocyte activation in pulsatile and rotary ventricular assist device patients

Artificial Organs

Volumn 38, Issue 6, 2014, Pages 447-455

  Woolley, Joshua R ^a,b,c   Teuteberg, Jeffrey J ^c   Bermudez, Christian A ^c,d   Bhama, Jay K ^c,d   Lockard, Kathleen L ^c   Kormos, Robert L ^b,c,d   Wagner, William R ^a,b,e  

^a University of Pittsburgh   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c MERCY HOSPITAL OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Artificial organs; Circulatory assist devices; Immunology; Inflammatory cells; Left ventricular assist devices; Neutrophils; Systemic inflammation

Indexed keywords

ARTIFICIAL ORGANS; FIBER OPTIC SENSORS; LEFT VENTRICULAR ASSIST DEVICES; PATHOLOGY;

ASSIST DEVICE; CIRCULATORY ASSIST DEVICE; DEVICE DESIGN; INFLAMMATORY CELLS; LEUCOCYTES; NEUTROPHILE; POST-OPERATIVE DAYS; PULSATILES; SYSTEMIC INFLAMMATION; VENTRICULAR ASSIST DEVICE;

CHEMICAL ACTIVATION;

CD11B ANTIGEN; MILRINONE; REACTIVE OXYGEN METABOLITE; BIOLOGICAL MARKER;

ADULT; ARTICLE; BIVENTRICULAR ASSIST DEVICE; CARDIOPULMONARY BYPASS; CELL ACTIVATION; DEVICE INFECTION; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RIGHT VENTRICULAR ASSIST DEVICE; THORAX DRAINAGE; VENTRICULAR ASSIST DEVICE; AGED; BLOOD; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEMATOCRIT; IMMUNOLOGY; LEUKOCYTE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROSTHESIS; PROSTHESIS IMPLANTATION; PROSTHESIS-RELATED INFECTIONS; RISK FACTOR; SURGICAL WOUND INFECTION; TIME; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; GRANULOCYTES; HEART FAILURE; HEART-ASSIST DEVICES; HEMATOCRIT; HUMANS; LEUKOCYTE COUNT; LEUKOCYTES; MACROPHAGE-1 ANTIGEN; MALE; MIDDLE AGED; PENNSYLVANIA; PREDICTIVE VALUE OF TESTS; PROSTHESIS DESIGN; PROSTHESIS IMPLANTATION; PROSTHESIS-RELATED INFECTIONS; RISK FACTORS; SURGICAL WOUND INFECTION; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84901918375     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/aor.12200     Document Type: Article

References (26)

1. Holman WL, Park SJ, Long JW, etal. Infection in permanent circulatory support: experience from the REMATCH trial. J Heart Lung Transplant 2004;23:1359-1365.
2. Sharma V, Deo SV, Stulak JM, etal. Driveline infections in left ventricular assist devices: implications for destination therapy. Ann Thorac Surg 2012;94:1381-1386.
3. Schaffer JM, Allen JG, Weiss ES, etal. Infectious complications after pulsatile-flow and continuous-flow left ventricular assist device implantation. J Heart Lung Transplant 2011;30:164-174.
4. Ankersmit HJ, Tugulea S, Spanier T, etal. Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Lancet 1999;354:550-555.
5. Shive MS, Salloum ML, Anderson JM. Shear stress-induced apoptosis of adherent neutrophils: a mechanism for persistence of cardiovascular device infections. Proc Natl Acad Sci USA 2000;97:6710-6715.
6. Shive MS, Brodbeck WG, Colton E, Anderson JM. Shear stress and material surface effects on adherent human monocyte apoptosis. J Biomed Mater Res 2002;60:148-158.
7. Deng MC, Erren M, Tjan TD, etal. Left ventricular assist system support is associated with persistent inflammation and temporary immunosuppression. Thorac Cardiovasc Surg 1999;47:s326-331.
8. Klotz S, Vahlhaus C, Riehl C, Reitz C, Sindermann JR, Scheld HH. Pre-operative prediction of post-VAD implant mortality using easily accessible clinical parameters. J Heart Lung Transplant 2010;29:45-52.
9. Interagency Registry of Mechanically Assisted Circulatory Support. Manual of Operations, Version 2.3. Available at: http://www.uab.edu/ctsresearch/intermacs/manuals.htm. Accessed March 2008.
10. Donnenberg VS, Donnenberg AD. Identification, rare-event detection and analysis of dendritic cell subsets in broncho-alveolar lavage fluid and peripheral blood by flow cytometry. Front Biosci 2003;8:s1175-1180.
11. Franke A, Lante W, Kurig E, Zoller LG, Weinhold C, Markewitz A. Hyporesponsiveness of T cell subsets after cardiac surgery: a product of altered cell function or merely a result of absolute cell count changes in peripheral blood? Eur J Cardiothorac Surg 2006;30:64-71.
12. Rudensky B, Yinnon AM, Shutin O, etal. The cellular immunological responses of patients undergoing coronary artery bypass grafting compared with those of patients undergoing valve replacement. Eur J Cardiothorac Surg 2010;37:1056-1062.
13. Holman WL, Kirklin JK, Naftel DC, etal. Infection after implantation of pulsatile mechanical circulatory support devices. J Thorac Cardiovasc Surg 2010;139:1632-1636.
14. Holman WL, Pamboukian SV, McGiffin DC, Tallaj JA, Cadeiras M, Kirklin JK. Device related infections: are we making progress? J Card Surg 2010;25:478-483.
15. Gordon RJ, Weinberg AD, Pagani FD, etal. Prospective, multicenter study of ventricular assist device infections. Circulation 2013;127:691-702.
16. Galinanes M, Watson C, Trivedi U, Chambers DJ, Young CP, Venn GE. Differential patters of neutrophil adhesion molecules during cardiopulmonary bypass in humans. Circulation 1996;94:s364-369.
17. Takala A, Jousela I, Jansson SE, etal. Markers of systemic inflammation predicting organ failure in community-acquired septic shock. Clin Sci (Lond) 1999;97:529-538.
18. Rinder CS, Fontes M, Mathew JP, Rinder HM, Smith BR. Neutrophil CD11b upregulation during cardiopulmonary bypass is associated with postoperative renal injury. Ann Thorac Surg 2003;75:899-905.
19. Yamazaki S, Inamori S, Nakatani T, Suga M. Activated protein C attenuates cardiopulmonary bypass-induced acute lung injury through the regulation of neutrophil activation. J Thorac Cardiovasc Surg 2011;141:1246-1252.
20. Diehl P, Aleker M, Helbing T, etal. Enhanced microparticles in ventricular assist device patients predict platelet, leukocyte and endothelial cell activation. Interact Cardiovasc Thorac Surg 2010;11:133-137.
21. Loebe M, Koster A, Sanger S, etal. Inflammatory response after implantation of a left ventricular Novacor device. ASAIO J 2001;47:272-274.
22. Asimakopoulos G, Taylor KM. Effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules. Ann Thorac Surg 1998;66:2135-2144.
23. Takala AJ, Jousela IT, Takkunen OS, etal. Time course of β2-integrin CD11b/CD18 (Mac-1, αMβ2) upregulation after CABG surgery. Scand J Thorac Cardiovasc Surg 1996;30:141-148.
24. Walzog B, Jeblonski F, Zakrzewicz A, Gaehtgens P. β2 integrins (CD11/CD18) promote apoptosis of human neutrophils. FASEB J 1997;11:1177-1186.
25. Kirklin JK, Naftel DC, Kormos RL, etal. Fifth INTERMACS annual report: risk factor analysis from more than 6000 mechanical circulatory support patients. J Heart Lung Transplant 2013;32:141-156.
26. Nagpal AD, Larsen BK, Smedira NG, Soltesz EG. Endoscopic tunneling of HeartMate II left ventricular assist device driveline. J Thorac Cardiovasc Surg 2013;145:297-298.